Open AccessNew strategy for suppressing the growth of lung cancer cells harboring mutations in the ATP‐binding region of EGFR by targeting the molecular motor MYO1D
Author(s) -
Ko YooSeung,
Kang Hyuno,
Bae Jeong A,
Kim Sung Jin,
Kim Nacksung,
Chung Ik Joo,
Moon KyungSub,
Rho Jin Kyung,
Kim Hangun,
Ha HyungHo,
Oh InJae,
Kim Kyung Keun
Publication year - 2021
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.515
Subject(s) - afatinib , cancer research , t790m , epidermal growth factor receptor , osimertinib , protein kinase domain , mutant , tyrosine kinase , medicine , erbb , gene knockdown , lung cancer , targeted therapy , kinase , cancer , biology , receptor , gefitinib , erlotinib , cell culture , microbiology and biotechnology , gene , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom